FTRE
Fortrea Holdings Inc.
NASDAQ: FTRE · HEALTHCARE · BIOTECHNOLOGY
$11.50
+8.90% today
Updated 2026-04-30
Market cap
$998.82M
P/E ratio
—
P/S ratio
0.37x
EPS (TTM)
$-10.81
Dividend yield
—
52W range
$4 – $19
Volume
1.5M
Fortrea Holdings Inc. (FTRE) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | — | $4.37B | $4.29B | $4.33B | $3.58B |
| Cash & equivalents | — | $94.60M | $112.00M | $108.60M | $118.50M |
| Current assets | — | $1.12B | $1.25B | $1.25B | $948.20M |
| Total liabilities | — | $1.11B | $945.30M | $2.62B | $2.22B |
| Current liabilities | — | $826.70M | $699.00M | $778.40M | $949.50M |
| Long-term debt | — | — | — | $1.57B | $1.05B |
| Shareholder equity | — | $3.26B | $3.34B | $1.71B | $1.36B |
| Retained earnings | — | $-148.40M | $-276.00M | $-68.50M | $-397.00M |
| Accounts receivable | — | $949.80M | $1.05B | $1.01B | $694.00M |
| Inventory | — | — | — | $35.30M | — |
| Goodwill | — | $2.08B | $2.00B | $1.74B | $1.71B |